Violation Tracker Individual Record

Company: 
Cephalon, Inc.
Current Parent Company: 
Teva Pharmaceutical Industries
Penalty: 
$6,150,000
Year: 
2008
Date: 
September 29, 2008
Offense Group: 
healthcare-related offenses
Primary Offense: 
off-label or unapproved promotion of medical products
Violation Description: 

Cephalon agreed to pay $6.15 million to settle allegations it marketed its drugs Actiq, Gabitril and Provigil for unapproved uses, leading to a huge increase in off-label prescription with significant health and safety risks. This was a separate Connecticut settlement in addition to the federal/multistate settlement.

Level of Government: 
state
Action Type: 
agency action
Agency: 
Connecticut Attorney General
Civil or Criminal Case: 
civil
Facility State: 
Connecticut
HQ Country of Parent: 
Israel
Ownership Structure of Parent: 
publicly traded
Major Industry of Parent: 
pharmaceuticals
Specific Industry of Parent: 
pharmaceuticals
Source Notes: 
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note: 
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.